REGN : REGENERON PHARMACEUTICALS stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue and EPS Prognosis by Technical Analysis
| year | Average | Low | High | Change from close on 2023-09-22 |
|---|---|---|---|---|
| 2023 | $858.91 | $836.01 | $881.17 | 4.13% |
| 2024 | $884.85 | $848.33 | $903.3 | 7.28% |
| 2025 | $833.5 | $768.91 | $885.9 | 1.05% |
| 2026 | $921.0 | $894.92 | $930.11 | 11.66% |
| 2027 | $944.13 | $923.43 | $958.42 | 14.46% |
| 2028 | $901.57 | $884.57 | $935.4 | 9.3% |
| 2029 | $909.9 | $880.83 | $999.67 | 10.31% |
| 2030 | $1088.68 | $1024.51 | $1132.26 | 31.99% |
| 2031 | $1083.24 | $963.61 | $1112.13 | 31.33% |
| 2032 | $783.59 | $739.98 | $878.77 | -5.0% |
| 2033 | $671.18 | $552.98 | $762.83 | -18.63% |
The 43 Wall Street analysts offering REGENERON PHARMACEUTICALS stock forecast in the last 6 months have average price target of
$893.77 with a high forecast of $1050.0 and a low forecast of $650.0.
The average REGENERON PHARMACEUTICALS stock forecast represents a 8.36%
increase from the last price of $824.840026855469.
From AI system, total return is 2366.52% from 4098 forecasts.
For REGENERON PHARMACEUTICALS stock forecast for 2023, 3 predictions are offered for each month of 2023 with average REGENERON PHARMACEUTICALS stock
forecast of $858.91, a high forecast of $881.17, and a low forecast of $836.01.
The average REGENERON PHARMACEUTICALS stock forecast 2023 represents a 4.13%
increase from the last price of $824.840026855469.
For REGENERON PHARMACEUTICALS stock forecast for 2024, 12 predictions are offered for each month of 2024 with average REGENERON PHARMACEUTICALS stock
forecast of $884.85, a high forecast of $903.3, and a low forecast of $848.33.
The average REGENERON PHARMACEUTICALS stock forecast 2024 represents a 7.28%
increase from the last price of $824.840026855469.
For REGENERON PHARMACEUTICALS stock forecast for 2026, 12 predictions are offered for each month of 2026 with average REGENERON PHARMACEUTICALS stock
forecast of $921.0, a high forecast of $930.11, and a low forecast of $894.92.
The average REGENERON PHARMACEUTICALS stock forecast 2026 represents a 11.66%
increase from the last price of $824.840026855469.
For REGENERON PHARMACEUTICALS stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average REGENERON PHARMACEUTICALS stock
forecast of $901.57, a high forecast of $935.4, and a low forecast of $884.57.
The average REGENERON PHARMACEUTICALS stock forecast 2028 represents a 9.3%
increase from the last price of $824.840026855469.
For REGENERON PHARMACEUTICALS stock forecast for 2031, 12 predictions are offered for each month of 2031 with average REGENERON PHARMACEUTICALS stock
forecast of $1083.24, a high forecast of $1112.13, and a low forecast of $963.61.
The average REGENERON PHARMACEUTICALS stock forecast 2031 represents a 31.33%
increase from the last price of $824.840026855469.
For REGENERON PHARMACEUTICALS stock forecast for 2033 (10 year), 9 predictions are offered for each month of 2033 with average REGENERON PHARMACEUTICALS stock
forecast of $671.18, a high forecast of $762.83, and a low forecast of $552.98.
The average REGENERON PHARMACEUTICALS stock forecast 2033 represents a -18.63%
decrease from the last price of $824.840026855469.
Please, see more forecasts below.
REGN : REGENERON PHARMACEUTICALS stock forecast by Wall Street Analysts
The average REGENERON PHARMACEUTICALS stock forecast from last 6 month is $893.77, and this show a 4.14% increase in average from the prior price target of the each prediction. Also, this average forecast of $893.77 represents a 5.83% increase from the past average forecast of $844.5, 6 months ago from 28 wall street analysts.
REGENERON PHARMACEUTICALS stock forecast for upcoming days
| Date | Price Target | Change |
|---|---|---|
| 2023-09-26 | $808.46 | -1.99% |
| 2023-09-27 | $785.83 | -2.80% |
| 2023-09-28 | $755.73 | -3.83% |
| 2023-09-29 | $747.08 | -1.14% |
| 2023-10-02 | $721.64 | -3.41% |
REGN : Long term REGENERON PHARMACEUTICALS stock forecast for 2022, 2023 (1 year) - 2025 - 2027 (5 year) - 2030, and 2032 (10 year)
Forecast for 2023 Oct. is $836.01 , for 2024 Sep. is $854.80 , for 2027 Sep. is $954.20 , for 2028 Sep. is $890.75 , for 2032 Sep. is $748.35 , and for 2033 Sep. is $552.98.
REGN : REGENERON PHARMACEUTICALS stock forecast for 2023
| Date | Price Target | Change |
|---|---|---|
| 2023 Oct. | $836.01 | 1.35% |
| 2023 Nov. | $859.54 | 2.82% |
| 2023 Dec. | $881.17 | 2.52% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2024
| Date | Price Target | Change |
|---|---|---|
| 2024 Jan. | $897.48 | 1.85% |
| 2024 Feb. | $903.30 | 0.65% |
| 2024 Mar. | $903.26 | -0.00% |
| 2024 Apr. | $902.13 | -0.12% |
| 2024 May. | $901.89 | -0.03% |
| 2024 Jun. | $902.66 | 0.09% |
| 2024 Jul. | $900.25 | -0.27% |
| 2024 Aug. | $885.12 | -1.68% |
| 2024 Sep. | $854.80 | -3.43% |
| 2024 Oct. | $848.33 | -0.76% |
| 2024 Nov. | $860.75 | 1.46% |
| 2024 Dec. | $858.24 | -0.29% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2025
| Date | Price Target | Change |
|---|---|---|
| 2025 Jan. | $858.04 | -0.02% |
| 2025 Feb. | $774.29 | -9.76% |
| 2025 Mar. | $768.91 | -0.70% |
| 2025 Apr. | $771.89 | 0.39% |
| 2025 May. | $794.04 | 2.87% |
| 2025 Jun. | $832.98 | 4.90% |
| 2025 Jul. | $840.65 | 0.92% |
| 2025 Aug. | $854.55 | 1.65% |
| 2025 Sep. | $866.53 | 1.40% |
| 2025 Oct. | $875.91 | 1.08% |
| 2025 Nov. | $878.27 | 0.27% |
| 2025 Dec. | $885.90 | 0.87% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2026
| Date | Price Target | Change |
|---|---|---|
| 2026 Jan. | $894.92 | 1.02% |
| 2026 Feb. | $906.90 | 1.34% |
| 2026 Mar. | $916.23 | 1.03% |
| 2026 Apr. | $922.59 | 0.69% |
| 2026 May. | $925.96 | 0.36% |
| 2026 Jun. | $929.45 | 0.38% |
| 2026 Jul. | $930.11 | 0.07% |
| 2026 Aug. | $928.72 | -0.15% |
| 2026 Sep. | $926.73 | -0.21% |
| 2026 Oct. | $924.39 | -0.25% |
| 2026 Nov. | $923.39 | -0.11% |
| 2026 Dec. | $922.62 | -0.08% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2027
| Date | Price Target | Change |
|---|---|---|
| 2027 Jan. | $923.43 | 0.09% |
| 2027 Feb. | $924.78 | 0.15% |
| 2027 Mar. | $928.01 | 0.35% |
| 2027 Apr. | $937.81 | 1.06% |
| 2027 May. | $942.84 | 0.54% |
| 2027 Jun. | $948.93 | 0.65% |
| 2027 Jul. | $953.02 | 0.43% |
| 2027 Aug. | $954.02 | 0.10% |
| 2027 Sep. | $954.20 | 0.02% |
| 2027 Oct. | $958.42 | 0.44% |
| 2027 Nov. | $956.62 | -0.19% |
| 2027 Dec. | $947.48 | -0.95% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2028
| Date | Price Target | Change |
|---|---|---|
| 2028 Jan. | $935.40 | -1.28% |
| 2028 Feb. | $924.75 | -1.14% |
| 2028 Mar. | $915.22 | -1.03% |
| 2028 Apr. | $906.87 | -0.91% |
| 2028 May. | $901.02 | -0.65% |
| 2028 Jun. | $897.48 | -0.39% |
| 2028 Jul. | $895.04 | -0.27% |
| 2028 Aug. | $893.15 | -0.21% |
| 2028 Sep. | $890.75 | -0.27% |
| 2028 Oct. | $888.40 | -0.26% |
| 2028 Nov. | $886.18 | -0.25% |
| 2028 Dec. | $884.57 | -0.18% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2029
| Date | Price Target | Change |
|---|---|---|
| 2029 Jan. | $883.61 | -0.11% |
| 2029 Feb. | $882.33 | -0.15% |
| 2029 Mar. | $881.30 | -0.12% |
| 2029 Apr. | $880.83 | -0.05% |
| 2029 May. | $881.44 | 0.07% |
| 2029 Jun. | $884.06 | 0.30% |
| 2029 Jul. | $890.37 | 0.71% |
| 2029 Aug. | $901.83 | 1.29% |
| 2029 Sep. | $919.57 | 1.97% |
| 2029 Oct. | $943.07 | 2.56% |
| 2029 Nov. | $970.69 | 2.93% |
| 2029 Dec. | $999.67 | 2.99% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2030
| Date | Price Target | Change |
|---|---|---|
| 2030 Jan. | $1024.51 | 2.49% |
| 2030 Feb. | $1042.46 | 1.75% |
| 2030 Mar. | $1053.52 | 1.06% |
| 2030 Apr. | $1060.34 | 0.65% |
| 2030 May. | $1066.59 | 0.59% |
| 2030 Jun. | $1077.63 | 1.04% |
| 2030 Jul. | $1101.85 | 2.25% |
| 2030 Aug. | $1124.81 | 2.08% |
| 2030 Sep. | $1132.26 | 0.66% |
| 2030 Oct. | $1131.83 | -0.04% |
| 2030 Nov. | $1127.70 | -0.36% |
| 2030 Dec. | $1120.64 | -0.63% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2031
| Date | Price Target | Change |
|---|---|---|
| 2031 Jan. | $1112.13 | -0.76% |
| 2031 Feb. | $1103.33 | -0.79% |
| 2031 Mar. | $1095.74 | -0.69% |
| 2031 Apr. | $1090.43 | -0.48% |
| 2031 May. | $1087.71 | -0.25% |
| 2031 Jun. | $1087.20 | -0.05% |
| 2031 Jul. | $1088.72 | 0.14% |
| 2031 Aug. | $1091.76 | 0.28% |
| 2031 Sep. | $1094.87 | 0.29% |
| 2031 Oct. | $1095.71 | 0.08% |
| 2031 Nov. | $1087.63 | -0.74% |
| 2031 Dec. | $963.61 | -11.40% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2032
| Date | Price Target | Change |
|---|---|---|
| 2032 Jan. | $878.77 | -8.80% |
| 2032 Feb. | $857.81 | -2.39% |
| 2032 Mar. | $834.63 | -2.70% |
| 2032 Apr. | $799.18 | -4.25% |
| 2032 May. | $769.92 | -3.66% |
| 2032 Jun. | $749.51 | -2.65% |
| 2032 Jul. | $739.98 | -1.27% |
| 2032 Aug. | $741.02 | 0.14% |
| 2032 Sep. | $748.35 | 0.99% |
| 2032 Oct. | $756.27 | 1.06% |
| 2032 Nov. | $762.15 | 0.78% |
| 2032 Dec. | $765.42 | 0.43% |
REGN : REGENERON PHARMACEUTICALS stock forecast for 2033
| Date | Price Target | Change |
|---|---|---|
| 2033 Jan. | $762.83 | -0.34% |
| 2033 Feb. | $751.44 | -1.49% |
| 2033 Mar. | $732.15 | -2.57% |
| 2033 Apr. | $706.51 | -3.50% |
| 2033 May. | $677.67 | -4.08% |
| 2033 Jun. | $648.80 | -4.26% |
| 2033 Jul. | $620.00 | -4.44% |
| 2033 Aug. | $588.23 | -5.12% |
| 2033 Sep. | $552.98 | -5.99% |
Frequently Asked Questions about REGENERON PHARMACEUTICALS stock forecast
Is REGENERON PHARMACEUTICALS a good long term stock?
From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2023 Oct. is $836.010788897293 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2024 Sep. is $854.795403187422 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2027 Sep. is $954.200543519303 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock can be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2028 Sep. is $890.749742517591 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2032 Sep. is $748.348318795822 From REGENERON PHARMACEUTICALS stock forecast , REGENERON PHARMACEUTICALS (REGN) stock cannot be a good investment choice. According to Tudal, the REGENERON PHARMACEUTICALS stock price forecast for 2033 Sep. is $552.977917991428
Is REGENERON PHARMACEUTICALS stock overvalued?
REGENERON PHARMACEUTICALS (REGN) stock is expected to go UP . Therefore, Tudal would say that REGENERON PHARMACEUTICALS (REGN) stock is NOT overvalued.
Will REGENERON PHARMACEUTICALS stock price go up?
Yes. The REGENERON PHARMACEUTICALS stock price forecast for 2024 Sep. is $854.795403187422
Is REGENERON PHARMACEUTICALS stock a good buy now?
Since closing price on 2023-09-22 is $824.840026855469 and forecast for 2024 Sep. is $854.80, REGENERON PHARMACEUTICALS stock is a good 1 year investment.